Join us at 10th German Pharm-Tox Summit (GPTS)

News of March 19th, 2025

We will be at the German Pharm-Tox Summit (GPTS) and our colleague Dr. Ruwen Böhm will co-chair the session on Pharmacogenetic testing as an inclusion/exclusion criterion in clinical trials and consequences for the label by AGAH.

This session will cover

Discussions of academia (Prof. Dr. Dr. Cascorbi from University of Kiel), industry (Dr. Zühlsdorf ) and Regulatory Authority Representative (Dr. Scholl from BfArM).

With the key topics:

• Joint development of pharmaceuticals and test methods should start already in early phases.
• An exciting example showcasing possibilities for a CYP2D6-dependent drug

GPTS, the 91st Annual Meeting of the Deutsche Gesellschaft für Experimentelle und Klinische Pharmakologie und Toxikologie (DGPT) is held in cooperation with AGAH, APHAR, GDCh FG UCOET, SETAC-GLB and STS on March 25-28 in Hannover.

Find here more information on GPTS and details on the session